Clinical Trials Sponsored by Janssen Pharmaceuticals

Total 22126 results

Jonsson Comprehensive Cancer Center
Novartis Pharmaceuticals

Withdrawn

Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer

Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer

United States
Janssen-Ortho LLC
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine

Migraine | Common Migraine | Classic Migraine
Peking Union Medical College Hospital
Xian-Janssen Pharmaceutical Ltd.

Active, not recruiting

Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis

Amyloidosis; Systemic

China
Johnson & Johnson Pharmaceutical Research & Development...
Janssen-Cilag Ltd.

Completed

A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies.

Neoplasms
Janssen Inc.

Completed

Golimumab for Adherence in Rheumatoid Arthritis (GO FAR)

Arthritis, Rheumatoid

Canada
Janssen Inc.

Completed

An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients (POISE)

Human Immunodeficiency Virus (HIV)

Canada
Janssen, LP

Completed

A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder

Diabetes Mellitus | Schizophrenia
Janssen, LP

Completed

A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.

Schizophrenia | Schizoaffective Disorder
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia

Dementia | Alzheimer Disease | Dementia, Vascular
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia

Psychotic Disorders | Schizophrenia
Janssen Inc.

Completed

A Study of Participants With Advanced Prostate Cancer in Canada (GURC)

Prostatic Neoplasms

Canada
Janssen Inc.

Completed

An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada (CanCARE)

Diabetes Mellitus, Type 2

Canada
Janssen Inc.

Completed

An Observational Study of Case Managed Versus Non-case Managed Initiation of Hemodialysis (PROSTARRT)

Chronic Kidney Disease

Canada
Janssen Inc.

Completed

The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera Endoscopy (ICE)

Crohn's Disease

Canada
Janssen Inc.

Completed

Remicade Infusion Management Program (RemiTRAC)

Arthritis, Rheumatoid | Crohn Disease

Canada
Janssen, LP

Completed

A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder
Janssen, LP

Completed

A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.

Schizophrenia | Schizoaffective Disorder
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia

Schizophrenia | Psychotic Disorder
Scott C. Woller, MD
Janssen Pharmaceuticals

Not yet recruiting

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism (eVTE)

Deep Vein Thrombosis | Hospitalism | Venous Thromboembolic Disease | Pulmonary Embolism and Thrombosis

United States
National Institute of Allergy and Infectious Diseases...
Janssen Pharmaceuticals

Completed

A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS

HIV Infections | Histoplasmosis

United States
Janssen Inc.

Completed

A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting (COSMiC)

Prostatic Neoplasms

Canada
Janssen Inc.

Completed

Biologic Treatment Registry Across Canada (BioTRAC)

Arthritis, Rheumatoid | Arthritis, Psoriatic | Spondyloarthritis, Axial

Canada
Janssen Inc.

Completed

A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis (X-PLORE)

Psoriasis

United States, Poland, Canada, Belgium, Germany
Janssen Inc.

Terminated

Observational Study of Golimumab Intravenous Infusion (GO-IV)

Rheumatoid Arthritis

Canada
Janssen, LP

Completed

Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA) (SOURCE)

Schizophrenia

United States
Janssen, LP

Completed

A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.

Schizophrenia
Janssen, LP

Completed

Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia

Psychotic Disorders | Schizophrenia
Janssen, LP

Completed

A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

Schizophrenia | Schizoaffective Disorder
Bristol-Myers Squibb
Novartis; Clovis Oncology, Inc.; Janssen Pharmaceuticals; Exelixis

Recruiting

Pan Tumor Rollover Study

Cancer

United States, Israel, Spain, Italy, Germany, Australia, Belgium, China, Korea, Republic of, Greece, Japan, Argentina, Austria, Brazil, Canada, Chile, Denmark, Finland, France, Hungary, Ireland, Mexico, Netherlands, Poland, Romania, Russian... and more
University of Pittsburgh
Janssen Pharmaceuticals; American Association for Geriatric Psychiatry

Completed

Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus

Schizophrenia | Schizoaffective Disorder | Delusional Disorder

United States
Associated Scientists to Help Minimize Allergies
Eisai Inc.; Janssen Pharmaceuticals

Completed

Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.

Asthma | Gastroesophageal Reflux Disease

United States
CCTU-Core
Janssen Pharmaceuticals

Active, not recruiting

Antidepressant Trial With P2X7 Antagonist JNJ-54175446 (ATP)

Inflammation | Depressive Disorder, Major

United Kingdom
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Janssen Pharmaceuticals

Withdrawn

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Myxoid Liposarcoma | Stage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Round Cell Liposarcoma | Unresectable Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma

United States
National Institute of Allergy and Infectious Diseases...
Janssen Pharmaceuticals

Completed

A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea

HIV Infections | Cryptosporidiosis

United States
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Terminated

Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

Osteoarthritis, Knee | Osteoarthritis, Hip

United States, Poland, United Kingdom
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects

RSV Infection

United States
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

Hepatitis C

Belgium, United States, Puerto Rico, Netherlands
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Completed

To Assess the Patients' Ability to Self-Administer Fasinumab (FACT DEVICE)

Osteoarthritis, Knee | Osteoarthritis, Hip

United States
Alexza Pharmaceuticals, Inc.
Pharmaceutical Research Associates

Unknown

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Agitation,Psychomotor

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects

RSV Infection

United States
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

HIV Infections | Hepatitis C

France, Spain, United States, Germany
Tibotec Pharmaceuticals, Ireland
Tibotec Pharmaceutical Limited

Completed

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents (DIONE)

HIV-1 Infection

France, United States, Spain, Ukraine, United Kingdom, Ireland
Janssen Pharmaceutica N.V., Belgium
Bristol Myers Squibb Company (BMS)

Completed

A Study of Milvexian in Healthy Adult Females

Healthy Female

Belgium
Rhode Island Hospital
Emory University; Janssen Pharmaceutica N.V., Belgium

Unknown

Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of Antidepressant

Major Depression

United States
The Lymphoma Academic Research Organisation
Janssen Pharmaceutica N.V., Belgium

Terminated

Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas (BIBLOS)

B-cell Lymphoma

France, Belgium
Icahn School of Medicine at Mount Sinai
Janssen Pharmaceutica

Completed

Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder

Schizotypal Personality Disorder

United States
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Renal Impairment
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Participants

Hepatic Impairment
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Completed

Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip (FACT OA2)

Osteoarthritis, Knee | Osteoarthritis, Hip

United States

Clinical Trials Sponsored by Janssen Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations